K+ channel modulators for the treatment of neurological disorders and autoimmune diseases
- PMID: 18476673
- PMCID: PMC2714671
- DOI: 10.1021/cr078234p
K+ channel modulators for the treatment of neurological disorders and autoimmune diseases
Figures
References
-
- Catterall W, Gutman GA. Pharmcol. Rev. 2005;57:385.
-
- Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, Lazdunski M, Nichols CG, Seino S, Vandenberg CA. Pharmacol. Rev. 2005;57:509. - PubMed
-
- Goldstein SA, Bayliss DA, Kim D, Lesage F, Plant LD, Rajan S. Pharmacol. Rev. 2005;57:527. - PubMed
-
- Wei AD, Gutman GA, Aldrich R, Chandy KG, Grissmer S, Wulff H. Pharmacol. Rev. 2005;57:463. - PubMed
-
- Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stuhmer W, Wang X. Pharmacol. Rev. 2005;57:473. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
